Comprehensive overview of Nrf2-related epigenetic regulations involved in ischemia-reperfusion injury
Open Access
- 11 September 2022
- journal article
- review article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (15) , 6626-6645
Abstract
Ischemic disease is a class of diseases in which an organ is ischemic due to vascular occlusion, a major contributor to death and disability worldwide. However, when the blood flow is restored, more severe damage occurs than ischemia alone and is known as ischemic-reperfusion injury (IRI). During reperfusion, the imbalance between the production of reactive oxygen species (ROS) and buffering capacity of the antioxidant defense system results in cell damage and death. Nuclear factor E2-related factor 2 (Nrf2) significantly affects antioxidant stress damage. The function of Nrf2 in the pathological process of IRI has been widely discussed, but the impact of epigenetic modifications associated with Nrf2 remains unclear. This article provides a comprehensive overview of the role and mechanism of Nrf2-related epigenetic modifications in the IRI of various organs, including the brain, heart, liver, and kidney. In addition, we summarize agonists that may target epigenetic regulation of Nrf2, which may be beneficial in seeking more effective strategies to improve IRI.Keywords
This publication has 187 references indexed in Scilit:
- Functions of DNA methylation: islands, start sites, gene bodies and beyondNature Reviews Genetics, 2012
- Epigenetic CpG Demethylation of the Promoter and Reactivation of the Expression of Neurog1 by Curcumin in Prostate LNCaP CellsThe AAPS Journal, 2011
- Epigenetic ModificationsCirculation, 2011
- Regulation of chromatin by histone modificationsCell Research, 2011
- Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reductionBiochemical and Biophysical Research Communications, 2010
- microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell diseaseBlood, 2010
- Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic FeaturesClinical Cancer Research, 2010
- Toll-Like Receptor 9 Inhibition Confers Protection From Liver Ischemia–Reperfusion InjuryHepatology, 2010
- HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signalingJournal of Experimental Medicine, 2007
- Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung CancerPLOS Medicine, 2006